| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |